Fillmore, C. M., Xu, C., Desai, P. T., Berry, J. M., Rowbotham, S. P., Lin, Y., . . . Kim, C. F. (2015). EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumors to TopoII inhibitors. Nature.
Chicago Style CitationFillmore, Christine M., et al. "EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumors to TopoII Inhibitors." Nature 2015.
Cita MLAFillmore, Christine M., et al. "EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumors to TopoII Inhibitors." Nature 2015.
Atenció: Aquestes cites poden no estar 100% correctes.